A qualitative exploration of knowledge, attitudes and practices of hospital pharmacists towards adverse drug reaction reporting system in Lahore, Pakistan
Tóm tắt
Từ khóa
Tài liệu tham khảo
Patidar D, Rajput MS, Nirmal NP, Savitri W. Implementation and evaluation of adverse drug reaction monitoring system in a tertiary care teaching hospital in Mumbai, India. Interdiscip Toxicol. 2013;6(1):41–6.
WHO. International drug monitoring: the role of the hospital, report of a WHO meeting1969 18–23 1968.
WHO. Safer use of medicines: the basics. World Health Organisation Collaborating Centre for International Drug Monitoring, Uppsala. 2018. https://www.who-umc.org/safer-use-of-medicines/safer-use-of-medicines-the-basics/ .
WHO. Fast facts on pharmacovigilance. In: Essential medicines and health products. 2015. http://www.who.int/medicines/areas/quality_safety/safety_efficacy/PV_fast_facts/en/ .
Rolfes L, Wilkes S, Hunsel F, Puijenbroek E, Grootheest K. Important information regarding reporting of adverse drug reactions: a qualitative study. Int J Pharm Pract. 2014;22(3):231–3.
Centre UM. WHO Collaborating Centres. Uppsala Monitoring Centre. 2018. https://www.who-umc.org/global-pharmacovigilance/specialist-centres/who-collaborating-centres/ . Accessed April 15 2018.
UMC. What happens to reports of problems with medicines? Uppsala Monitoring Centre. 2018. https://www.who-umc.org/safer-use-of-medicines/safer-use-of-medicines-the-basics/what-happens-to-reports/ . Accessed April 15 2018.
MHRA. Yellowcard. Helping to make medicines safer. Medicines and Healthcare products Regulatory Agency. 2018. https://yellowcard.mhra.gov.uk /. Accessed April 19 2018.
Rabbur RS, Emmerton L. An introduction to adverse drug reaction reporting systems in different countries. Int J Pharm Pract. 2005;13(1):91–100.
FDA. MedWatch: The FDA Safety Information and Adverse Event Reporting Program. U.S. Food and Drug Administration. 2018. https://www.fda.gov/Safety/MedWatch/default.htm . Accessed April 19 2018.
AHRQ.gov . Sentinel Event Program. U.S. Department of Health and Human Services. 2013. https://psnet.ahrq.gov/resources/resource/26617/sentinel-event-program .
NCCMERP. Medication Errors. United States Pharmacopeial Convention. 2018. http://www.nccmerp.org /. Accessed April 19 2018.
Cox A. Broad Spectrum: Embracing ADR reporting could improve pharmacists' standing. Pharm J 2002;269 14.
Centre NZP. CARM. 2018. https://nzphvc.otago.ac.nz/carm/ . Accessed April 20 2018.
Mes K, Berg L, Grootheest AV. Attitudes of community pharmacists in the Netherlands towards adverse drug reaction reporting. Int J Pharm Pract. 2002;10(4):267–72.
Palaian. S. Pharmacovigilance Practices and Activities: Issues, Challenges, and Future Direction. In: Ibrahim. M, Wertheimer. A, Babar. Z, editors. Social and Administrative Aspects of Pharmacy in Low- and Middle-Income Countries. Elsevier; 2018. p. 145–162.
NHSRC. Achievements. Ministry of National Health Services, Regulations and Coordination, Government of Pakistan. 2018. http://www.nhsrc.gov.pk/index.html . Accessed April 2 2018.
Tribunal JI. Batch J093. The Pathology of Negligence (Report of the Judicial Inquiry Tribunal to Determine the Causes of Deaths of Patients of the Punjab Institute of Cardiology, Lahore in 2011–2012)2012.
Department H. http://health.punjab.gov.pk/Services_Package . Governemnt of Punjab. 2018. http://health.punjab.gov.pk/Services_Package .
Observatory-EMRO RHS. Health Systems Profile-Pakistan. World Health Organization. 2007. http://apps.who.int/medicinedocs/documents/s17305e/s17305e.pdf .
WHO. Deadly medicines contamination in Pakistan. World health Organization. 2013. http://www.who.int/features/2013/pakistan_medicine_safety/en/ . Accessed April 15 2018.
Atif. M, Ahmad. M, Saleem. Q, Curley. L, Zaman. M, Babar. Z. Pharmaceutical Policy in Pakistan. In: Babar. Z, editor. Pharmaceutical Policy in Countries with Developing Healthcare Systems. Springer International 2017. p. 25–44.
DRAP. Pharmacy Services Division. 2017. http://dra.gov.pk/Home/PharmacyServicesDivision .
Shamim S, Sharib SM, Malhi SM, Muntaha S-u, Raza H, Ata S, et al. Adverse drug reactions (ADRS) reporting: awareness and reasons of under-reporting among health care professionals, a challenge for pharmacists. SpringerPlus. 2016;5(1):1778.
Centre UM. VigiFlow. Uppsala Monitoring Centre. 2018. https://www.who-umc.org/global-pharmacovigilance/vigiflow/ . Accessed April 15 2018.
Wazir HK. DRAP to introduce regulations for post-marketing surveillance of drugs. Pakistan Today. 2017.
Department W. Population Profile Punjab. Government of The Punjab. 2017. http://www.pwd.punjab.gov.pk/population_profile . Accessed April 15 2018.
Review WP. Lahore Population 2017. 2017. http://worldpopulationreview.com/world-cities/lahore-population/ .
Punjab PDCU. Pharmacy Pharmacovigilance Division. Provincial Drug Control Unit Punjab. 2017. https://mss.punjab.gov.pk/PublicHome/PharmacyPharmacovigilanceDivision . Accessed April 15 2018.
Chaudary A. Punjab reacts to adverse drugs. The Dawn. 2012;
Drug Safety Alerts [database on the Internet]. Provincial Drug Control Unit Punjab. 2018. Available from: https://sites.google.com/prod/view/pdcup/divisions/drug-safety-alerts . Accessed: April 10 2018.
Smith F. Research methods in pharmacy practice: Pharmaceutical Press; 2002.
Berg B. Qualitative research methods for the social sciences, MA: Pearsons education. Inc: Inc. 2009.
Dolan Mullen P, Reynolds R. The potential of grounded theory for health education research: linking theory and practice. Health Educ Monogr. 1978;6(3):280–94.
Sajjad M, Akhtar S, Ullah MI. Impact of social media marketing on health awareness in Lahore. Pak J Soc Sci (PJSS). 2015;35(1):335–45.
Ghulam M, Saeed R, Tahir M. Adverse drug reaction reporting system at different hospitals of Lahore, Pakistan-an evaluation and patient out come analysis. J App Pharm. 2013;4(01):713–9.
Iffat W, Shakeel S, Rahim N, Anjum F, Nesar S, Ghayas S. Pakistani physicians knowledge and attitude towards reporting adverse drug reactions. Afr J Pharm Pharmacol. 2014;8(14):379–85.
Paveliu MS, Bengea-Luculescu S, Mihai T, Paveliu SF. Perception on adverse drug reaction reporting by physicians working in southern Romania. Maedica. 2013;8(1):17.
Vessal G, Mardani Z, Mollai M. Knowledge, attitudes, and perceptions of pharmacists to adverse drug reaction reporting in Iran. Pharm World Sci. 2009;31(2):183–7.
Belton K, Group EPR. Attitude survey of adverse drug-reaction reporting by health care professionals across the European Union. Eur J Clin Pharmacol. 1997;52(6):423–7.
Belton KJ, Lewis SC, Payne S, Rawlins M, Wood S. Attitudinal survey of adverse drug reaction reporting by medical practitioners in the United Kingdom [see comments]. Br J Clin Pharmacol. 1995;39(3):223–226.
Elkalmi RM, Hassali MA, Ibrahim MIM, Liau SY, Awaisu AA. Qualitative study exploring barriers and facilitators for reporting of adverse drug reactions (ADRs) among community pharmacists in Malaysia. J Pharm Health Serv Res. 2011;2(2):71–8.
Cheema E, Haseeb A, Khan TM, Sutcliffe P, Singer DR. Barriers to reporting of adverse drugs reactions: a cross sectional study among community pharmacists in United Kingdom. Pharm Pract. 2017;15(3)
Jose J, Jimmy B, Al-Ghailani ASH, Al Majali MA. A cross sectional pilot study on assessing the knowledge, attitude and behavior of community pharmacists to adverse drug reaction related aspects in the Sultanate of Oman. Saudi Pharm J. 2014;22(2):163–9.
Hadi MA, Neoh CF, Zin RM, Elrggal ME, Cheema E. Pharmacovigilance: pharmacists’ perspective on spontaneous adverse drug reaction reporting. Integrated Pharmacy Res Pract. 2017;6:91.
Green CF, Mottram DR, Rowe PH, Pirmohamed M. Attitudes and knowledge of hospital pharmacists to adverse drug reaction reporting. Br J Clin Pharmacol. 2001;51(1):81–6.
Hadi MA, Helwani R, Long CM. Facilitators and barriers towards adverse drug reaction reporting: perspective of Malaysian hospital pharmacists. J Pharm Health Serv Res. 2013;4(3):155–8.
Suyagh M, Farah D, Farha RA. Pharmacist’s knowledge, practice and attitudes toward pharmacovigilance and adverse drug reactions reporting process. Saudi Pharm J. 2015;23(2):147–53.
Obara T, Yamaguchi H, Satoh M, Iida Y, Sakai T. Prevalence, determinants, and reasons for the non-reporting of adverse drug reactions by pharmacists in the Miyagi and Hokkaido regions of Japan. Adv Pharmacoepidemiol Drug Saf. 2015;4(191):2167–1052.
Liu J, Zhou Z, Yang S, Feng B, Zhao J, Liu H, et al. Factors that affect adverse drug reaction reporting among hospital pharmacists in western China. Int J Clin Pharm. 2015;37(3):457–64.
Abdel-Latif MM, Abdel-Wahab BA. Knowledge and awareness of adverse drug reactions and pharmacovigilance practices among healthcare professionals in Al-Madinah Al-Munawwarah, Kingdom of Saudi Arabia. Saudi Pharm J. 2015;23(2):154–61.
Fadare JO, Enwere OO, Afolabi A, Chedi B, Musa A. Knowledge, attitude and practice of adverse drug reaction reporting among healthcare workers in a tertiary Centre in Northern Nigeria. Trop J Pharm Res. 2011;10(3):235–42.
Hashmi FK, Hassali MA, Khalid A, Saleem F, Aljadhey H, Bashaar M. A qualitative study exploring perceptions and attitudes of community pharmacists about extended pharmacy services in Lahore, Pakistan. BMC Health Serv Res. 2017;17(1):500.
Nishtar. S. Health and the 18th Amendment- Retaining national functions in devolution.
Prochaska JO, Velicer WF. The transtheoretical model of health behavior change. Am J Health Promot. 1997;12(1):38–48.
DAWN. One pharmacist needed for 50 hospital beds: expert. 2016. https://www.dawn.com/news/1289197 .
Nation T. Govt urged to fill 6,000 vacancies of pharmacist. 2017. https://nation.com.pk/14-Mar-2017/govt-urged-to-fill-6-000-vacancies-of-pharmacists .
GOP. SO (ND) 10–6/2007. In: Department H, editor. Punjab: Government of Punjab; 2010.
UMC. Communication in pharmacovigilance. Uppsala Monitoring Centre. 2018. https://www.who-umc.org/global-pharmacovigilance/communication-in-pharmacovigilance/patient-centered-communications/ . Accessed April 15 2018.
Banerjee AK, Ingate S. Web-based patient-reported outcomes in drug safety and risk management. Drug Saf. 2012;35(6):437–46.
WHO. The Role of the Pharmacist in the Health Care System. 2017. http://apps.who.int/medicinedocs/en/d/Jh2995e/1.3.html . Accessed April 20 2018.
Herdeiro MT, Figueiras A, Polónia J, Gestal-Otero J. Influence of pharmacists’ attitudes on adverse drug reaction reporting. Drug Saf. 2006;29(4):331–40.
Sharrad AK. Pharmacists'knowledge, attitude and practice about adverse drug reaction in Basra/Iraq. Int J Pharm Sci Res. 2017;8(5):2309.
Vallano A, Cereza G, Pedròs C, Agustí A, Danés I, Aguilera C, et al. Obstacles and solutions for spontaneous reporting of adverse drug reactions in the hospital. Br J Clin Pharmacol. 2005;60(6):653–8.
Organization WH. Pharmacovigilance: ensuring the safe use of medicines. 2004.